Why the titration schedule exists Tirzepatide is a dual GIP/GLP-1 receptor agonist
many competitors charge $50$150 more per month at higher dose levels
Zhou X, Qian H, Zhang D, et al
Gummies can't carry meaningful protein or fiber density, and many contain added sugar that works against the blood-sugar goals of the medication
FDA-Approved Eligibility Criteria: Primary Qualification (BMI-Based): You qualify if: BMI 30 (obesity category), OR BMI 27 (overweight category) PLUS at least one weight-related health condition BMI Reference Guide: Weight-Related Health Conditions (For BMI 27-29.9): Qualifying conditions include: Type 2 diabetes or prediabetes Hypertension (high blood pressure) High cholesterol or dyslipidemia Obstructive sleep apnea Cardiovascular disease Polycystic ovary syndrome (PCOS) Non-alcoholic fatty liver disease Osteoarthritis exacerbated by weight If you have BMI 27-29.9 with any of these conditions, you qualify
Supplements aren't held to the same standards by the FDA as medications, which means you can't always know exactly what's in your supplement or in what amounts